La vendita allo scoperto per TuSimple Hldgs dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di TuSimple Hldgs. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

TuSimple Hldgs (OTC:TSPH) Azioni, Report sulle vendite allo scoperto

TuSimple Holdings Inc is an autonomous technology company in the truck freight market. It has developed a technology for semi-trucks to build the Autonomous Freight Network (AFN) in partnership with shippers, carriers, railroads, freight brokers, fleet asset owners, and truck hardware partners. The company recognizes revenue from providing freight capacity services. TuSimple's two reportable geographic segments are the U.S. and APAC.

TUSIMPLE HOLDINGS INC A by TuSimple Holdings Inc.

TuSimple Holdings Inc

Janover, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JNVR#NASDAQ">JNVR</a>) (the "Company") announced today that it had raised approximately $42 million in an offering of convertible notes and warrants from Pantera Capital, Kraken, Arrington Capital, Protagonist, The Norstar Group, Third Party Ventures, Trammell Venture Partners, and 11 angel investors. The notes were sold in a private offering under Section 4(a)(2) under the Securities Act of 1933, as amended (the "Securities Act") and Regulation D promulgated thereunder.
The aggregate principal amount of the convertible notes sold in the offering was approximately $42 million, which are convertible into the Company's common stock, par value $0.00001 per share ("Common Stock"). The convertible notes accrue interest at a rate of 2.5% per year, paid in cash quarterly in arrears, and mature on April 6, 2030. The convertible notes are convertible at any time prior to the maturity date, conditioned on the requirement that the Company's market capitalization equaled or exceeded $100 million on the day prior to the conversion date. The conversion price will be set on the date that the Company's market capitalization first equals or exceeds $100 million to equal the last reported sale price of the Common Stock on The Nasdaq Stock Market, subject to a minimum conversion price of $4.81. For each $1,000 in principal amount of convertible notes purchased, warrants were issued to purchase (1) approximately 8.333 shares of Common Stock at an exercise price of $120 per share and (2) approximately 6.666 shares of Common Stock at an exercise price of $150 per share. The conversion price and exercise price, respectively, are subject to customary anti-dilution and dividend protections.

News

Offerings

JNVR

Janover Raises $42M In Convertible Notes And Warrants From Pantera Capital, Kraken, Arrington Capital, And Others, With Proceeds Aimed At Acquiring Digital Assets, Starting With The Solana Ecosystem, And Enhancing Efforts In The U.S. Public Markets

Shell PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHEL#NYSE">SHEL</a>) shares were trading lower in premarket on Monday after the company <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g44660686/shell-first-quarter-2025-update-note" rel="noreferrer noopener">revised&nbsp;its first-quarter&nbsp;outlook</a>.
For the&nbsp;first quarter, it cut the guidance for production at Integrated Gas to around 910 &#8211; 950 thousand boe/d (vs. the prior outlook of 930 – 990&nbsp;thousand boe/d) due to unplanned maintenance, mainly in Australia.
Also, Shell revised the outlook for Upstream to about 1,790 &#8211; 1,890 thousand boe/d <a target="_blank" href="https://www.benzinga.com/news/buybacks/25/01/43332871/shell-q4-lower-earnings-cost-reductions-dividend-boost-and-more" rel="noreferrer noopener">(vs. earlier outlook of 1,750 – 1,950 thousand boe/d)</a>, reflecting the completion of the SPDC divestment in March 2025.
In the Upstream segment, the company projects a share of profit / (loss) of joint ventures and associates of ~$200 million and exploration well write-offs of ~$0.1 billion in the quarter.
The company now projects Marketing sales volumes of&nbsp;around 2,500 &#8211; 2,900 thousand b/d (vs. earlier guidance of 2,500 – 3,000 thousand b/d), reflecting a lower contribution from Sectors &amp; Decarbonisation.
Shell anticipates refinery utilization of around&nbsp;83% – 87% (vs. prior outlook of 80% – 88%) and chemical manufacturing plant utilization of between&nbsp;79% – 83% <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">(vs. earlier guidance of 78% – 86%)</a>.
The company expects Trading &amp; Optimisation to be significantly higher than the fourth quarter of FY24 in Chemicals and Products segment.
The company also adjusted its LNG production forecast, now predicting between 6.4 million and 6.8 million metric tons from a previous&nbsp;guidance&nbsp;of <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g43327844/shell-plc-publishes-fourth-quarter-2024-press-release" rel="noreferrer noopener">6.6 million – 7.2 million metric tons</a>.
Last month, at Capital Markets Day 2025,&nbsp;Shell&nbsp;disclosed plans to increase shareholder distributions from&nbsp;30%-40%&nbsp;to&nbsp;40%-50%&nbsp;of cash flow from operations&nbsp;<a target="_blank" href="https://www.benzinga.com/news/guidance/25/03/44470278/shell-unveils-new-strategy-higher-buybacks-cost-cuts-and-10-annual-free-cash-flow-growth" rel="noreferrer noopener">(CFFO) throughout economic cycles</a>.
Shell has raised its structural cost reduction target from&nbsp;$2-3 billion by the end of 2025 to a cumulative&nbsp;$5-7 billion by 2028,&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">based on 2022 levels</a>.
Investors can gain exposure to the stock via&nbsp;Precidian ETFs Trust Shell plc ADRhedged&nbsp;(BATS:<a class="ticker" href="https://www.benzinga.com/stock/SHEH#BATS">SHEH</a>) and&nbsp;Abacus FCF Real Assets Leaders ETF&nbsp;(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ABLD#BATS">ABLD</a>).
Price Action: SHEL shares are trading lower by&nbsp;4.80%&nbsp;at&nbsp;$61.05 premarket at the last check on Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/guidance/25/04/44644795/brookfield-strikes-9-billion-deal-for-colonial-pipeline-shell-offloads-minority-stake" target="_blank" rel="noreferrer noopener">Brookfield Strikes $9 Billion Deal For Colonial Pipeline—Shell Offloads Minority Stake</a></li>
</ul>
Photo via Shutterstock

Equities

Large Cap

Movers

ABLD

AstraZeneca PLC ADRhedged Shell plc ADRhedged

SHEH

SHEL

Shell Lowers Q1 Production Outlook, Flags Write-Offs And Maintenance

Baird analyst David Tarantino maintains Domino's Pizza (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>) with a Outperform and lowers the price target from $510 to $500.

Price Target

Analyst Ratings

Baird Maintains Outperform on Domino's Pizza, Lowers Price Target to $500

UBS analyst Thomas Wadewitz downgrades United Airlines Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) from Buy to Neutral and lowers the price target from $107 to $59.

Downgrades

UBS Downgrades United Airlines Holdings to Neutral, Lowers Price Target to $59

Baird analyst David Tarantino maintains Chipotle Mexican Grill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) with a Outperform and lowers the price target from $68 to $62.

Baird Maintains Outperform on Chipotle Mexican Grill, Lowers Price Target to $62

<a href="https://www.jnj.com/media-center/press-releases/european-commission-approves-johnson-johnsons-subcutaneous-darzalex-daratumumab-based-quadruplet-regimen-for-the-treatment-of-patients-with-newly-diagnosed-multiple-myeloma-regardless-of-transplant-eligibility" title="https://www.jnj.com/media-center/press-releases/european-commission-approves-johnson-johnsons-subcutaneous-darzalex-daratumumab-based-quadruplet-regimen-for-the-treatment-of-patients-with-newly-diagnosed-multiple-myeloma-regardless-of-transplant-eligibility">https://www.jnj.com/media-center/press-releases/european-commission-approves-johnson-johnsons-subcutaneous-darzalex-daratumumab-based-quadruplet-regimen-for-the-treatment-of-patients-with-newly-diagnosed-multiple-myeloma-regardless-of-transplant-eligibility</a>

Biotech

General

Johnson & Johnson Announces The European Commission Has Approved Its Subcutaneous Darzalex-Based Quadruplet Regimen For The Treatment Of Patients With Newly Diagnosed Multiple Myeloma, Regardless Of Transplant Eligibility

Baird analyst David Tarantino maintains Cava Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>) with a Outperform and lowers the price target from $125 to $105.

CAVA

Baird Maintains Outperform on Cava Group, Lowers Price Target to $105

Baird analyst David Tarantino maintains Cheesecake Factory (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAKE#NASDAQ">CAKE</a>) with a Neutral and lowers the price target from $50 to $46.

CAKE

Baird Maintains Neutral on Cheesecake Factory, Lowers Price Target to $46

Baird analyst David Tarantino maintains Dutch Bros (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BROS#NYSE">BROS</a>) with a Outperform and lowers the price target from $80 to $66.

BROS

Baird Maintains Outperform on Dutch Bros, Lowers Price Target to $66

Gilat Satellite Networks Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILT#NASDAQ">GILT</a>) announced on Monday that it has <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g44663247/gilat-awarded-up-to-23-million-multi-year-contract-to-service-satellite-transportable-terminal-uni" rel="noreferrer noopener">secured a contract</a> to deliver ongoing sustainment and support services for Satellite Transportable Terminal (STT) units deployed globally in support of U.S. Department of Defense (DoD) operations.
The agreement includes a base term with optional extensions of up to five years, bringing the total potential contract value to $23 million.
Under the terms of the deal, Gilat Defense will provide critical program management, field services, and technical support to ensure the operational readiness and long-term reliability of these vital communication systems.
"This contract reinforces the ongoing critical role our SATCOM systems play in supporting the U.S. DoD's global operations. We remain committed to delivering superior performance and service to our trusted defense partners worldwide," said Nicole Robinson, President of Gilat DataPath.
The announcement follows a $6 million <a href="https://www.benzinga.com/pressreleases/25/03/g44137836/gilat-receives-6-million-defense-contract-to-provide-military-communications-solutions-in-asia-pac" target="_blank" rel="noreferrer noopener">order</a> last month, in which Gilat's Defense Division was selected to supply an Asian-Pacific military organization with its advanced SkyEdge II-c platform. The system will support secure communications across fixed and mobile defense sites and feature enhanced air interface cybersecurity.
Price Action: At the last check on Monday, Gilat shares were trading higher by 4.35% at $5.76 premarket.

Contracts

GILT

Gilat Wins Defense Support Deal Worth Up To $23 Million For Global SATCOM Services

Baird analyst David George upgrades KeyCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEY#NYSE">KEY</a>) from Neutral to Outperform and maintains the price target from $18 to $18.

Upgrades

Baird Upgrades KeyCorp to Outperform, Maintains Price Target to $18

UBS analyst Joshua Spector upgrades Sealed Air (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEE#NYSE">SEE</a>) from Neutral to Buy and maintains the price target from $38 to $38.

UBS Upgrades Sealed Air to Buy, Maintains Price Target to $38

Earnings

HTLM

Homestolife FY 2024 GAAP EPS $(0.11) Down From $0.02 YoY, Sales $4.173M Down From $5.072M YoY

Collaboration Seeks to Enhance Ukraine's Mine Action Capabilities with Safe Pro's Cutting-Edge Patented AI Technology
Safe Pro Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPAI#NASDAQ">SPAI</a>) ("Safe Pro" or the "Company"), a leader in artificial intelligence (AI)-powered defense and security solutions, has entered into a multi-year Memorandum of Understanding (MOU) with Ukraine's Center of Excellence for Mine Action and Environmental Security (the "Center of Excellence" or "the Center"). Together, they will exam ways to integrate Safe Pro's patented AI-powered image processing technology, SpotlightAI&#x2122;, into Ukraine's demining methodologies and training programs to modernize the nation's approach to landmine detection and clearance.

SPAI

Safe Pro Group Enters Multi-Year MOU With Ukraine's Center Of Excellence For Mine Action To Integrate SpotlightAI Into Ukraine's Demining Methodologies And Training Programs To Enhance Landmine Detection And Clearance

Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) will release earnings results for the second quarter, before the <a href="https://www.benzinga.com/quote/WBA/earnings">opening bell on Tuesday, April 8.</a>
Analysts expect the company to report quarterly earnings at 53 cents per share, down from $1.2 per share in the year-ago period. According to data from Benzinga Pro, Walgreens projects quarterly revenue at $38.0 billion, compared to $37.05 billion a year earlier.
On March 6, Walgreens Boots Alliance entered an agreement to be acquired by private equity firm Sycamore Partners.
With the recent buzz around Walgreens, some investors may also be eyeing potential gains from the company's dividends. As of now, Walgreens offers an annual dividend yield of 9.36%, which is a quarterly dividend amount of 25 cents per share ($1.00 a year).  
So, how can investors exploit its dividend yield to pocket a regular $500 monthly?
To earn $500 per month or $6,000 annually from dividends alone, you would need an investment of approximately $64,080 or around 6,000 shares. For a more modest $100 per month or $1,200 per year, you would need $12,816 or around 1,200 shares.
To calculate: Divide the desired annual income ($6,000 or $1,200) by the dividend ($1.00 in this case). So, $6,000 / $1.00 = 6,000 ($500 per month), and $1,200 / $1.00 = 1,200 shares ($100 per month).
Note that dividend yield can change on a rolling basis as the dividend payment and stock price fluctuate over time.
How that works: The dividend yield is computed by dividing the annual dividend payment by the stock&#8217;s current price.
For example, if a stock pays an annual dividend of $2 and is currently priced at $50, the dividend yield would be 4% ($2/$50). However, if the stock price increases to $60, the dividend yield drops to 3.33% ($2/$60). Conversely, if the stock price falls to $40, the dividend yield rises to 5% ($2/$40).
Similarly, changes in the dividend payment can impact the yield. If a company increases its dividend, the yield will also increase, provided the stock price stays the same. Conversely, if the dividend payment decreases, so will the yield.
WBA Price Action: Shares of Walgreens fell 3.4% to close at $10.68 on Friday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44645517/wall-streets-most-accurate-analysts-give-their-take-on-3-health-care-stocks-with-over-4-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Markets

Trading Ideas

How To Earn $500 A Month From Walgreens Stock Ahead Of Q2 Earnings

UBS analyst Joshua Spector downgrades LyondellBasell Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYB#NYSE">LYB</a>) from Neutral to Sell and lowers the price target from $76 to $51.

UBS Downgrades LyondellBasell Industries to Sell, Lowers Price Target to $51

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2025/04/04/final-trades-jpmorgan-amazon-rh-and-the-2-year-treasury.html">Halftime Report Final Trades</a>,&#8221; Jason Snipe of Odyssey Capital Advisors said Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) is 30% off the 52-week high level.
Adding support to his choice, WestPark Capital analyst Curtis Shauger, on April 1, initiated coverage on Amazon.com with a Buy rating and announced a price target of $280.
Stephen L. Weiss of Short Hills Capital Partners named U.S. 2 Year Treasury as <a href="https://www.benzinga.com/topic/treasury-yields">his final trade</a>.
Jim Lebenthal of Cerity Partners picked JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) ahead of first-quarter earnings.
JPMorgan will host a conference call to review first-quarter financial results on Friday, April 11. Analysts expect the bank to report quarterly earnings at $4.65 per share, up from $4.44 per share in the year-ago period. JPMorgan projects quarterly revenue of $44.05 billion, compared to $41.93 billion a year earlier.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Bryn Talkington of Requisite Capital Management said RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) is another name she likes in her Vietnam basket.
On the earnings front, RH, on April 2, reported fourth-quarter revenue of $812.41 million, missing the consensus estimate of $829.56 million, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. The luxury retailer reported fourth-quarter adjusted earnings of $1.58 per share, missing analyst estimates of $1.92 per share.
Price Action:
<ul>
<li>JPMorgan shares dipped 7.5% to close at $210.28 on Friday.</li>
<li>Amazon shares fell 4.2% to close at $171.00 during Friday's session.</li>
<li>RH shares declined 2.5% to settle at $145.66 on Friday.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44645517/wall-streets-most-accurate-analysts-give-their-take-on-3-health-care-stocks-with-over-4-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields</a></li>
</ul>
Image: Shutterstock

Media

AMZN

Amazon, JPMorgan, RH And More: CNBC's 'Final Trades'

Baird analyst David George upgrades First Horizon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FHN#NYSE">FHN</a>) from Neutral to Outperform and maintains the price target from $22 to $22.

Baird Upgrades First Horizon to Outperform, Maintains Price Target to $22

UBS analyst Joshua Spector upgrades Axalta Coating Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXTA#NYSE">AXTA</a>) from Neutral to Buy and lowers the price target from $42 to $40.

AXTA

UBS Upgrades Axalta Coating Systems to Buy, Lowers Price Target to $40

Baird analyst David George upgrades Fifth Third Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FITB#NASDAQ">FITB</a>) from Neutral to Outperform and maintains the price target from $47 to $47.

Comments

TuSimple Hldgs

Vendite allo scoperto

TuSimple Hldgs (OTC:TSPH) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO